Clinical Trials Directory

Trials / Unknown

UnknownNCT01717092

Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented in Chinese population. We conducted a prospective, long-term, follow-up study to assess the incidence of symptomatic CTPH in consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism. Patients with unexplained persistent dyspnea during follow-up underwent transthoracic echocardiography and, if supportive findings were present, ventilation-perfusion lung scanning and pulmonary angiography. CTPH was considered to be present if systolic and mean pulmonary-artery pressures exceeded 40 mm Hg and 25 mm Hg, respectively; pulmonary-capillary wedge pressure was normal; and there was angiographic evidence of disease.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2012-10-30
Last updated
2014-02-27

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01717092. Inclusion in this directory is not an endorsement.